Fluoxetine vs. Brief Psychotherapy for Major Depression

• Status: Completed
• Trial end date: 2004-12-01
• Target enrollment: 0
• Participant gender: All

Summary

In this study we compare two treatments for major depression - fluoxetine and brief psychodynamic psychotherapy. In addition to more traditional outcome measures, we also measure the densities of 5HT-1A and D-2 receptors before and after the treatment. The main hypothesis is that brief psychotherapy is as effective as fluoxetine.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Turku
• Collaborators: Finnish State Grant; KELA
• Treatments: Fluoxetine

Criteria

Inclusion Criteria:

• MDD (mild to moderate)

• HDRS 15 or more, age 20-60 years

• No treatment for preceding 4 months

• No DSM-IV axis I or II comorbidity

• No severe somatic illness

• No contraindications for fluoxetine treatment